Khaled El‐Shami
Papers
1
Total Citations
5
H-Index
1
About
Khaled El-Shami is a prominent oncologist and clinical researcher whose work centers on head and neck cancers, with a particular focus on oropharyngeal squamous cell carcinoma (OPSCC). His major contributions lie in pioneering de-escalation treatment strategies that aim to reduce the long-term morbidity associated with standard chemoradiation. In a landmark 2017 Phase II study, El-Shami investigated a novel approach combining induction chemotherapy with transoral robotic surgery (TORS) as definitive therapy for locally advanced OPSCC. This work challenged the prevailing standard of care by seeking to spare patients the lifelong toxicities of radiation while maintaining oncologic efficacy. Though the study has accrued 5 citations to date, its conceptual impact is significant, representing a shift toward function-preserving, personalized surgical oncology. El-Shami’s research is distinguished by its patient-centered focus, addressing the critical balance between cancer control and quality of life. His work continues to influence clinical trial design and treatment paradigms in head and neck oncology, offering a promising avenue for reducing treatment-related harm in a disease where survivorship outcomes are increasingly paramount.
Research Focus
Key Achievements
Top Papers
- 1